.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Redefining Advanced Prostate Cancer with Novel Imaging

EP. 1: Considerations for Initiating ADT in Prostate Cancer

March 13th 2018

EP. 2: Challenges Associated With ADT for Prostate Cancer

March 13th 2018

EP. 3: Risk Stratification in Nonmetastatic Prostate Cancer

March 13th 2018

EP. 4: Newly Diagnosed Metastatic Prostate Cancer Treatment

March 13th 2018

EP. 5: Sequencing Therapy With ADT Combinations

March 13th 2018

EP. 6: Detecting Newly Diagnosed Metastatic Prostate Cancer

March 13th 2018

EP. 7: Treatment Challenges in Nonmetastatic CRPC

March 13th 2018

EP. 8: Guidelines for Early Detection of Metastasis in CRPC

March 13th 2018

EP. 9: CRPC: Goals of Imaging for the Detection of Metastasis

March 13th 2018

EP. 10: Treatment Goals in M0 CRPC

March 13th 2018

EP. 11: AR-Targeted Therapies in CRPC

March 13th 2018

EP. 12: Other Emerging Combination Approaches in RCC

March 13th 2018

EP. 13: Assessing Treatment Response in M0 CRPC

March 13th 2018

EP. 14: Utilizing AR-Targeted Therapies in CRPC

March 13th 2018

EP. 15: Improvements in Detecting and Treating Metastatic CRPC

March 13th 2018

EP. 16: Hereditary Prostate Cancer Testing in Practice

March 13th 2018

EP. 17: Managing Advanced Prostate Cancer in the Future

March 13th 2018